U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C27H36N6O3
Molecular Weight 492.6131
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CPG-52364

SMILES

COC1=C(OC)C=C2C(NCCN3CCOCC3)=NC(=NC2=C1)C4=CC=C(C=C4)N5CCN(C)CC5

InChI

InChIKey=TUOZJWZCVIRDKO-UHFFFAOYSA-N
InChI=1S/C27H36N6O3/c1-31-10-12-33(13-11-31)21-6-4-20(5-7-21)26-29-23-19-25(35-3)24(34-2)18-22(23)27(30-26)28-8-9-32-14-16-36-17-15-32/h4-7,18-19H,8-17H2,1-3H3,(H,28,29,30)

HIDE SMILES / InChI

Approval Year

Name Type Language
CPG-52364
Common Name English
6,7-DIMETHOXY-2-(4-(4-METHYLPIPERAZIN-1-YL)PHENYL)-N-(2-MORPHOLINOETHYL)QUINAZOLIN-4-AMINE
Systematic Name English
4-QUINAZOLINAMINE, 6,7-DIMETHOXY-2-(4-(4-METHYL-1-PIPERAZINYL)PHENYL)-N-(2-(4-MORPHOLINYL)ETHYL)-
Systematic Name English
Code System Code Type Description
FDA UNII
5TVM84YK6F
Created by admin on Sat Dec 16 11:36:40 UTC 2023 , Edited by admin on Sat Dec 16 11:36:40 UTC 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
CPG-52364
Created by admin on Sat Dec 16 11:36:40 UTC 2023 , Edited by admin on Sat Dec 16 11:36:40 UTC 2023
PRIMARY Description: CPG-52364 a small molecule TLR7/8/9 antagonist, has recently completed phase 1 clinical trial for SLE therapy. Toll-like receptors (TLRs) are a family of type I transmembrane receptors and the central components of the innate immune system. Human TLR3, TLR7, TLR8, and TLR9 are expressed on endosomal membranes in the cells and recognize pathogenderived nucleic acid molecular patterns.5 However, recognition of endogenous immune complexes containing self-nucleic acids as PAMPs or DAMPs contributes to certain autoimmune diseases, such as systemic lupus erythematosus (SLE), psoriasis,7 arthritis, and multiple sclerosis.8 Therefore, inhibition of these recognition signals is expected to have therapeutic value. (last updated: 11/11/2015).
PUBCHEM
25105690
Created by admin on Sat Dec 16 11:36:40 UTC 2023 , Edited by admin on Sat Dec 16 11:36:40 UTC 2023
PRIMARY
CAS
1093135-60-4
Created by admin on Sat Dec 16 11:36:40 UTC 2023 , Edited by admin on Sat Dec 16 11:36:40 UTC 2023
PRIMARY